{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-104541","form_type":"8-K","ticker":"CGTX","cik":"0001455365","company_name":"COGNITION THERAPEUTICS INC","filed_at":"2024-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.484304+00:00","generated_at":"2026-05-30T23:16:09.774609+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Cognition Therapeutics furnishes investor presentation on amyloid beta oligomer approach","bullets":["Presentation titled 'Targeting Amyloid Beta Oligomers: A Disruptive Approach to the Treatment of CNS Disorders' dated September 2024 made available.","No specific financial results, clinical data, or guidance changes disclosed in filing or exhibit.","Presentation furnished for Regulation FD; not incorporated by reference into SEC filings."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-104541","json":"https://secwatch.observer/filing/0001104659-24-104541.json","markdown":"https://secwatch.observer/filing/0001104659-24-104541.md","text":"https://secwatch.observer/filing/0001104659-24-104541.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1455365/000110465924104541/0001104659-24-104541-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1455365/000110465924104541/tm2425259d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T23:16:09.774609+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}